skip to main content
Language:
Search Limited to: Search Limited to: Resource type Show Results with: Show Results with: Search type Index

The impact of COVID-19 on patients with asthma

European Respiratory Journal, 2021-03, Vol.57 (3), p.2003142 [Peer Reviewed Journal]

Copyright ©ERS 2021. ;2020. This work is licensed under http://creativecommons.org/licenses/by-nc/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2021. This work is licensed under http://creativecommons.org/licenses/by-nc/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;Copyright ©ERS 2021 2021 ;ISSN: 0903-1936 ;EISSN: 1399-3003 ;DOI: 10.1183/13993003.03142-2020 ;PMID: 33154029

Digital Resources/Online E-Resources

Citations Cited by
  • Title:
    The impact of COVID-19 on patients with asthma
  • Author: Izquierdo, José Luis ; Almonacid, Carlos ; González, Yolanda ; Del Rio-Bermudez, Carlos ; Ancochea, Julio ; Cárdenas, Remedios ; Lumbreras, Sara ; Soriano, Joan B
  • Subjects: Adolescent ; Adult ; Aged ; Asthma - complications ; COVID-19 - complications ; COVID-19 - epidemiology ; Female ; Humans ; Male ; Middle Aged ; Original ; Retrospective Studies ; Young Adult
  • Is Part Of: European Respiratory Journal, 2021-03, Vol.57 (3), p.2003142
  • Description: An association between the severity of coronavirus disease 2019 (COVID-19) and the presence of certain chronic conditions has been suggested. However, unlike influenza and other viruses, the disease burden of COVID-19 in patients with asthma has been less evident. To understand the impact of COVID-19 in patients with asthma. Using big-data analytics and artificial intelligence through the SAVANA Manager clinical platform, we analysed clinical data from patients with asthma from January 1 to May 10, 2020. Out of 71 182 patients with asthma, 1006 (1.41%) suffered from COVID-19. Compared to asthmatic individuals without COVID-19, patients with asthma and COVID-19 were significantly older (55 42 years), predominantly female (66% 59%), smoked more frequently and had higher prevalence of hypertension, dyslipidaemias, diabetes and obesity. Allergy-related factors such as rhinitis and eczema were less common in asthmatic patients with COVID-19 (p<0.001). In addition, higher prevalence of these comorbidities was observed in patients with COVID-19 who required hospital admission. The use of inhaled corticosteroids (ICS) was lower in patients who required hospitalisation due to COVID-19, as compared to non-hospitalised patients (48.3% 61.5%; OR 0.58, 95% CI 0.44-0.77). Although patients treated with biologics (n=865; 1.21%) showed increased severity and more comorbidities at the ear, nose and throat level, COVID-19-related hospitalisations in these patients were relatively low (0.23%). Patients with asthma and COVID-19 were older and at increased risk due to comorbidity-related factors. ICS and biologics are generally safe and may be associated with a protective effect against severe COVID-19 infection.
  • Publisher: England: European Respiratory Society Journals Ltd
  • Language: English
  • Identifier: ISSN: 0903-1936
    EISSN: 1399-3003
    DOI: 10.1183/13993003.03142-2020
    PMID: 33154029
  • Source: Coronavirus Research Database
Back to results list
INSPIRE LIBRARY - TON DUC THANG UNIVERSITY (84-028) 37 755 057 Feedback
19 Nguyen Huu Tho St. Dist.7, HCM thuvien@tdtu.edu.vn

Copyright © 2017 INSPIRE LIBRARY - TON DUC THANG UNIVERSITY

Searching Remote Databases, Please Wait